Oric Pharmaceuticals, Inc. Balance Sheet
ORIC / Health Care|8 years of annual SEC 10-K data (FY2018-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
Oric Pharmaceuticals, Inc. had $409M in total assets and $384M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $45.7M | $59.4M | $23.4M | $66.8M | $226.0M | $78.4M | $89.2M | - |
| Current Assets | $288.5M | $262.3M | $212.6M | $210.5M | $240.5M | $296.7M | $90.0M | - |
| PP&E (Net) | $2.4M | $2.9M | $2.9M | $3.3M | $2.4M | $2.0M | $2.2M | - |
| Total Assets | $408.9M | $274.1M | $252.0M | $247.2M | $298.6M | $299.0M | $94.1M | - |
| Current Liabilities | $20.4M | $24.8M | $20.5M | $15.4M | $15.2M | $9.0M | $5.4M | - |
| Total Debt | - | - | - | - | $10.5M | - | - | - |
| Shareholders' Equity | $384.4M | $243.1M | $224.1M | $222.4M | $273.0M | $289.8M | -$90.1M | -$64.4M |